CA50114-2 - 0x0000000000006AC0

Males & Females of Non-Childbearing Potential

Note

* Stipend may pay up to reflected amount.
Start Date: 
March 24, 2026 - 10:00am
End Date: 
July 8, 2026 - 10:15am

Study Details

Study Number: CA50114
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,000.00

Study Criteria

Age: 18 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed to prevent and treat blood clots.
Route of Administration: Injection subcutaneous
Blood Draws: 19

Study Schedule

Schedule Type: Short stays with returns
Study Length: 5 Night Stay & 10 Returns

Screening Dates:

Event Day Event Date
Thursday 3/12/2026

Doctor Exam Dates:

Event Day Event Date
Thursday 3/12/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 3/24/2026 10:00:00 AM Sunday 3/29/2026 10:00:00 AM 1 Phoenix
Return Tuesday 3/31/2026 7:15:00 AM Tuesday 3/31/2026 10:15:00 AM 1 Phoenix
Return Friday 4/3/2026 8:15:00 AM Friday 4/3/2026 10:00:00 AM 1 Phoenix
Return Wednesday 4/8/2026 8:15:00 AM Wednesday 4/8/2026 10:00:00 AM 1 Phoenix
Return Wednesday 4/15/2026 8:15:00 AM Wednesday 4/15/2026 10:00:00 AM 1 Phoenix
Return Wednesday 4/22/2026 8:15:00 AM Wednesday 4/22/2026 10:00:00 AM 1 Phoenix
Return Wednesday 5/6/2026 8:15:00 AM Wednesday 5/6/2026 10:00:00 AM 1 Phoenix
Return Wednesday 5/20/2026 8:15:00 AM Wednesday 5/20/2026 10:00:00 AM 1 Phoenix
Return Wednesday 6/3/2026 8:15:00 AM Wednesday 6/3/2026 10:00:00 AM 1 Phoenix
Return Wednesday 6/17/2026 8:15:00 AM Wednesday 6/17/2026 10:00:00 AM 1 Phoenix
Return Wednesday 7/8/2026 7:15:00 AM Wednesday 7/8/2026 10:15:00 AM 1 Phoenix